Ушбу иш иқтибос қилган ишлар

302 та иш

Иш: Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment

Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression
Yun Feng, Fang Li, Jing Yan +15
Мақола20215 иқтибос
ABI
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
Мақола20224 иқтибос
ABI
Evaluation of the Survival Rate and Clinical Outcome of Nanodrug Administration for the Treatment of Lung Cancer: A Systematic Review and Meta-analysis
Marzieh Khalili, Mandana Ebrahimi, Aylar Fazlzadeh +2
Шарҳ мақола20224 иқтибос
ABI
Oncolytic virotherapy
Stephen J. Russell, Kah-Whye Peng, John C. Bell
Шарҳ мақола20123 иқтибос
ABI
Global stabilization of the full attraction-repulsion Keller-Segel system
Hai‐Yang Jin, Zhi‐An Wang
Мақола20193 иқтибос
ABI
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum, Nitin Joshi, Wei Tao +2
Шарҳ мақола20183 иқтибос
ABI
Single-cell RNA analysis reveals the potential risk of organ-specific cell types vulnerable to SARS-CoV-2 infections
Zilong Zhang, Feifei Cui, Chen Cao +2
Мақола20213 иқтибос
ABI
Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis
Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi +12
Мақола20223 иқтибос
ABI
Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances
Meijun Zheng, Jianhan Huang, Aiping Tong +1
Шарҳ мақола20192 иқтибос
ABI
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
Zong Sheng Guo, Zuqiang Liu, David L. Bartlett
Шарҳ мақола20142 иқтибос
ABI
Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow–Derived Stroma
Shannon Kidd, Erika L. Spaeth, Keri Watson +5
Мақола20122 иқтибос
ABI
Going viral with cancer immunotherapy
Brian D. Lichty, Caroline J. Breitbach, David F. Stojdl +1
Шарҳ мақола20142 иқтибос
ABI
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Ta‐Chiang Liu, Evanthia Galanis, David H. Kirn
Шарҳ мақола20072 иқтибос
ABI
The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research
Eric Momin, Guillermo Vela, Hasan A. Zaidi +1
Мақола20102 иқтибос
ABI
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
Ling Qiao, Zhili Xu, Tiejun Zhao +5
Мақола20082 иқтибос
ABI
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells
Xiao-Xia Jiang, Yi Zhang, Bing Liu +4
Мақола20052 иқтибос
ABI
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo, Tony Reid, Leyo Ruo +23
Мақола20132 иқтибос
ABI
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Caroline J. Breitbach, Rozanne Arulanandam, Naomi De Silva +15
Мақола20132 иқтибос
ABI
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio +26
Мақола20152 иқтибос
ABI
Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?
Ann De Becker, Ivan Van Riet
Шарҳ мақола20162 иқтибос
ABI
Mesenchymal stem cells and immunomodulation: current status and future prospects
Fei Gao, Sheng‐Hao Chiu, Daniyal Motan +6
Шарҳ мақола20162 иқтибос
ABI
Human Umbilical Cord Wharton's Jelly Stem Cell Conditioned Medium Induces Tumoricidal Effects on Lymphoma Cells Through Hydrogen Peroxide Mediation
Hao Daniel Lin, Chui‐Yee Fong, Arijit Biswas +2
Мақола20162 иқтибос
ABI
Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia
Mohammad Jafari, Farahnaz Dadras, Hamid Reza Ghadimipour +2
Мақола20162 иқтибос
ABI
Immune System, Friend or Foe of Oncolytic Virotherapy?
Anna C. Filley, Mahua Dey
Шарҳ мақола20172 иқтибос
ABI
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
Shashi Gujar, Jonathan Pol, Youra Kim +2
Шарҳ мақола20172 иқтибос
ABI